a review of the pathophysiological basis and therapeutic interventions
Zhu, L., Huang, Y., Edirisinghe, I., Park, E., & Burton-Freeman, B
Poly-agonists : Drugs combining GLP-1 with other hormones (GIP, glucagon, amylin) to potentially increase weight loss
To find something useful you take out one toxin at a time and test it, looking for one that does something good
27,28 Meanwhile, adequate vitamin D supplementation may improve insulin resistance in T2DM, as the average age of diabetics is 5060 years
Moreover, combining both arms of the drug is justified best in this case by our research question, which investigates the overall effect of the GLP-1 receptor agonists in PD treatment, not to compare the effect of different doses of one drug in this drug family